| MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling D Venkatesh, NA O'Brien, F Zandkarimi, DR Tong, ME Stokes, DE Dunn, ... Genes & Development 34 (7-8), 526-543, 2020 | 190 | 2020 |
| The roles and regulation of MDM2 and MDMX: it is not just about p53 AM Klein, RM de Queiroz, D Venkatesh, C Prives Genes & Development 35 (9-10), 575-601, 2021 | 70 | 2021 |
| GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma S Suzuki, D Venkatesh, H Kanda, A Nakayama, H Hosokawa, E Lee, ... Cancer Research, 2022 | 58 | 2022 |
| p21 can be a barrier to ferroptosis independent of p53 D Venkatesh, BR Stockwell, C Prives Aging (Albany NY) 12 (18), 17800, 2020 | 46 | 2020 |
| Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine M Gigoux, MO Holmström, R Zappasodi, JJ Park, S Pourpe, CC Bozkus, ... Science Translational Medicine 14 (649), eaba4380, 2022 | 12 | 2022 |
| Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade A Ghosh, J Michels, R Mezzadra, D Venkatesh, L Dong, R Gomez, ... The Journal of Clinical Investigation 132 (18), 2022 | 8 | 2022 |
| p53 frameshift mutations couple loss-of-function with unique neomorphic activities DR Tong, W Zhou, C Katz, K Regunath, D Venkatesh, C Ihuegbu, ... Molecular Cancer Research 19 (9), 1522-1533, 2021 | 5 | 2021 |
| APR-246 enhances tumor immunogenicity even in the absence of p53 D Venkatesh, J Michels, C Liu, S Budhu, MM George, L Abrahmsen, ... Cancer Research 82 (12_Supplement), 1291-1291, 2022 | 1 | 2022 |
| Optimization of intermittent dosing strategies of KRAS G12C inhibitors in preclinical lung cancer model VE Navarro, V Panneton, L Dong, H Choi, D Venkatesh, R Maniyar, ... Cancer Research 84 (6_Supplement), 7274-7274, 2024 | | 2024 |
| APR-246 increases tumor antigenicity independent of p53 J Michels, D Venkatesh, C Liu, S Budhu, H Zhong, MM George, D Thach, ... Life Science Alliance 7 (1), 2024 | | 2024 |
| Paving the Way for Cancer Therapy a Nano Step at a Time D Venkatesh, T Merghoub Journal of Pharmacology and Experimental Therapeutics 384 (3), 327-330, 2023 | | 2023 |
| GLS2 shapes ferroptosis in hepatocellular carcinoma S Suzuki, D Venkatesh, T Tanaka, C Prives Oncotarget 14, 900, 2023 | | 2023 |
| 903 APR-246 induces an increase in tumor immunogenicity in a p53 independent manner D Venkatesh, J Michels, C Lu, S Budhu, M George, O Ouerfelli, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| SIGNAL-REGULATORY PROTEIN ALPHA (SIRP alpha) CONFERS TUMOR CELL RESISTANCE TO ANTI-TUMOR IMMUNITY CH Weng, L Hamadene, S Eghbali, D Venkatesh, S Monette, L Mangarin, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1191-A1191, 2022 | | 2022 |
| Generation of Genetic Maps Using the Travelling Salesman Problem (TSP) Algorithm D Venkatesh, T Mishra, VS Gogi | | |
